Exploratory Study on the Efficacy and Safety of Jmoon Transdermal Collagen Light Beauty Device on Facial Anti-aging

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400090845

Enrollment

Unknown

Registered

2024-10-14

Start date

2024-07-08

Completion date

Unknown

Last updated

2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial Aging

Interventions

The test group:Jmoon Transdermal Collagen Light Beauty Device, used once daily for 4 weeks

Eligibility

Sex/Gender

Female

Age

25 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1.Females aged 25-50 years (inclusive of 25 and 50 years). 2.Mild to moderate facial aging, lack of elasticity, rough and dull skin (refer to the skin aging scale). 3.Facial crow's feet, under-eye wrinkles, forehead lines, nasolabial folds, and glabellar lines. 4.No cosmetic procedures such as laser chemical peels within the past 3 months before the test. 5.Voluntarily participate in the test and sign the informed consent, maintaining original lifestyle during the test. 6.Able to comply with and participate in follow-up visits, adhere to daily photo check-ins, and promptly report any changes in health status or adverse reactions during the test. 7.Avoid excessive sun exposure during the test period

Exclusion criteria

Exclusion criteria: 1.Women who are pregnant, lactating, or intending to conceive. 2.Individuals with photosensitivity/scar constitution. 3.Patients currently participating in other clinical trials. 4.Patients with wounds, epidermal rupture, herpes/folliculitis at the test site. 5.Individuals whose test sites have scars, pigmentation, atrophy, port wine stains, or 6.other imperfections that affect the judgment of test results. 7.Patients with diabetes, tumors, asthma, autoimmune diseases, or other severe organic or mental diseases. Individuals who have taken oral antihistamines within the past week, applied any anti-inflammatory drugs to the test site within the past two months, or used retinoids, alpha hydroxy acids, salicylic acid, hydroquinone, etc., within the past three months.

Design outcomes

Primary

Measure	Time frame
Facial spots, texture, pores, and wrinkles;Facial stratum corneum hydration, sebum content, skin elasticity, firmness, glossiness;Facial dermal thickness and density;	—

Secondary

Measure	Time frame
Participant satisfaction score;	—

Countries

China

Contacts

Public ContactWei Fang

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine

Weifang081782@163.com+86 136 3660 2969

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026